News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced Biological Laboratories SA (ABL) Acquires Evivar Medical Assets and Further Enhances its IT Solutions and Personalized Healthcare Platform for Hepatitis B, Hepatitis C and HIV Infections


6/10/2013 10:03:15 AM

LUXEMBOURG & MELBOURNE, Australia--(BUSINESS WIRE)--Advanced Biological Laboratories S.A (ABL) today announced the acquisition of all the assets of Evivar Medical Pty Ltd (Evivar), which includes Evivar’s Hepatitis B virus (HBV) and C (HCV) web-based decision support tools for clinicians and the associated viral genome analysis systems (SeqHepB and SeqHepC), intellectual property portfolio, and all related commercial arrangements and operations.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES